ACM
BSX icon

Argentus Capital Management’s Boston Scientific BSX Stock Holding History

Argentus Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,841
Closed -$128K – 317
2014
Q3 		$128K Buy
+10,841
New +$137K 0.02% 314

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Argentus Capital Management's BSX Position: Q4 2014 in Review

Argentus Capital Management sold out of Boston Scientific (BSX) in Q4 2014, closing a stake of 10,841 shares — an estimated $128K sold.

Argentus Capital Management first reported a position in BSX in Q3 2014 and held it in 1 quarter. The position peaked at $128K in Q3 2014. 457 funds tracked by Wall St. Rank hold BSX as of Q4 2014.

  • Argentus Capital Management reported no remaining Boston Scientific position as of Q4 2014 after selling out during the quarter.
  • Argentus Capital Management sold 10,841 Boston Scientific shares in Q4 2014, an estimated $128K.
  • Argentus Capital Management first reported a position in Boston Scientific in Q3 2014 and held it in 1 quarter.
  • Argentus Capital Management's Boston Scientific position peaked at $128K in Q3 2014.
  • 457 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2014.

Based on Argentus Capital Management's 13F filing for Q4 2014, filed 12 Jan 2015.